Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110483346B reveals a visible-light photocatalytic method for synthesizing sulfonyl-substituted alpha-cyclopropyl styrenes, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN103351361B details a novel Pd-catalyzed oxidation route for Levocetirizine Dihydrochloride ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN101870703B details a novel disulfide porphyrin catalyst enabling efficient aerobic oxidation. Discover cost-effective manufacturing and supply chain advantages.
Novel industrial method for Dasatinib synthesis avoiding palladium catalysts, offering cost reduction and scalable production for pharmaceutical manufacturers.
Patent CN111423320A reveals a green synthesis of nervonic acid using Grignard reactions, offering high purity pharmaceutical intermediates with reduced environmental impact.
Novel one-pot synthesis using PEG-400 solvent offers high yield and green chemistry advantages for scalable pharmaceutical intermediate manufacturing.
Patent CN115385971A details a novel NMN preparation method using phosphorus pentoxide to eliminate arsenic residues and reduce wastewater phosphorus for cost-effective manufacturing.
Patent CN114478580A reveals a recyclable ionic liquid method for synthesizing pyrano thiazolo pyrimidine derivatives, offering high purity and reduced waste for API manufacturing.
Patent CN102746360B details novel camptothecin-steroid conjugates with enhanced antitumor activity. Discover cost-effective EDCI-DMAP synthesis routes for high-purity API intermediates.
Novel patent CN117567311A offers efficient ceramide preparation with simplified post-treatment and high purity for cosmetic and pharmaceutical applications.
Advanced patent CN104016954A method for nebivolol intermediate. High yield, >99% purity, scalable process for reliable pharmaceutical intermediate supplier.
Advanced NCP ligand iridium complexes enable efficient alkane dehydrogenation and α-alkylation with high selectivity and stability for industrial scale-up.
Patent CN112142750B reveals a green one-pot synthesis for triazolo pyrimidine derivatives using acidic ionic liquids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel copper-catalyzed method for beta-hydroxyethyl cinnamaldehyde. Reduces steps, lowers cost, ensures high purity for pharma and fragrance intermediates.
Novel preparation method for cefozopran hydrochloride ensures high purity and low solvent residue. Optimized for scalable API manufacturing and supply chain reliability.
Novel copper chelate synthesis patent offers enhanced antitumor activity. Reliable supply chain for high-purity pharmaceutical intermediates and cost-effective manufacturing.
Patent CN108484461A reveals metal-free thioamide synthesis. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.
Novel enzymatic synthesis route for high-purity chiral alcohol intermediate. Reduces cost and improves safety for pharmaceutical manufacturing supply chains.
Advanced diazotization route for N-methyl-2-fluoroaniline offers high yield and purity. A cost-effective solution for pharmaceutical intermediates manufacturing.
Patent CN110372463B reveals a metal-free sulfonamide synthesis using nitroarenes. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.